Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
about
Anti-biofilm Activity as a Health IssueAnalysis of bacterial biofilms using NMR-based metabolomicsCurrent concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureusEfficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivoIn vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pHNew Insight into Daptomycin Bioavailability and Localization in Staphylococcus aureus Biofilms by Dynamic Fluorescence ImagingFactors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.Penetration of daptomycin into bone and synovial fluid in joint replacement.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic ModelDaptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways.Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins.Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) databaseA combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.New approaches for treating staphylococcal biofilm infections.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii.How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?Successful Daptomycin Use in a Pediatric Patient With Acute, Bilateral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus.Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections.Random peptide mixtures inhibit and eradicate methicillin-resistant Staphylococcus aureus biofilms.An Activity of Thioacyl Derivatives of 4-Aminoquinolinium Salts towards Biofilm Producing and Planktonic Forms of Coagulase-Negative Staphylococci.Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.Tolerability of High Doses of Daptomycin in the Treatment of Prosthetic Vascular Graft Infection: A Retrospective Study.Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay usiEfficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.A multilayered electrospun graft as vascular access for hemodialysis.
P2860
Q26747450-AFF67668-272F-4EE5-9EE6-BC8888580291Q26851303-6D10536C-5BDB-4429-AF81-7161752010C5Q27023330-13F2F27B-9C1C-4CC7-89E7-507E40B1285DQ27324704-896D75ED-19D3-43EB-9CFF-3D4931CDA645Q28488311-C31079F7-0930-4C0D-B548-E4D98EAB6E09Q30788584-E58440B9-F8F5-4752-9799-7985D0EEF296Q33726771-A11CD65B-8704-4350-911C-63FBF295EB20Q33798246-E5D19C01-E0DC-4883-9D02-E226B7A9CA90Q34478074-69FC3B8E-CB9C-4BC1-A55C-0812DBF7887AQ34529085-601EF06A-20AB-4705-9297-9932FCAC4550Q34596619-4E171E90-D643-440F-8DEA-690A30EA44DEQ35179800-850B7967-7C9E-4581-93B2-1E20DFE33273Q35859931-2B2F0F2E-39B6-466C-9D96-E31705645789Q36073392-9C2A57AE-0C1A-4D9F-BD03-9C08576E2FDDQ36073400-3E93BA0D-2084-4C3C-B185-A4CD66C1050FQ36401160-FD5A813E-A2BE-4B0D-97F5-BF003424BF74Q36727985-FA20897C-4920-474D-A300-BA2FD4C5905AQ36752475-CBD2C6FA-A0CC-406A-8B60-D47F09BE78B8Q36929393-22C9A64D-52BF-4811-840E-6DCC3DFF3E10Q37026608-CF0504F4-1FF2-4B17-8C8F-F677A8ECD627Q37250189-DB1A327B-BC93-462B-91BB-D33703D3D45AQ37712972-BB378C5D-D328-4304-BC2E-0942706E5523Q37970722-87F7F0CC-8951-48F2-AF23-6D3BF7BFBF34Q38258649-1EAD2D16-78A6-42E7-B223-7E98036A68CEQ38577676-16C37391-856A-4E7F-A791-5E6AE71FCE7CQ39215691-987B6B07-1671-4B5B-B5B4-CF3E550F24BFQ39584788-33EFF9AA-6E96-408E-BB32-C9E3B9E51D8BQ40152803-916C2639-F428-44EB-9131-3E28AD027C7AQ40425288-D7B1EA8C-5306-487D-A985-854161A99B0BQ40631566-DE7741AB-F62F-48D9-8779-B1FC92B7B6C7Q40681546-5534D9B1-8123-4B66-A065-42C94DFC35EAQ40727716-C307222C-0D0D-458A-B491-A19A93406129Q40836726-BC6E09FE-108A-488F-AC48-EFA1FF220B29Q41000542-90BF8E86-E71F-4256-8DA9-F6939331ABC6Q41755464-17E7A8AE-E492-4B13-9556-A35D8DD60569Q42003344-E9D9BABB-5D0B-482E-8060-ECD5BD055AFCQ42036509-C76ED16D-E00A-4B95-BF46-1681876C8DC4Q42103662-7C96A4EC-9B5F-4D26-B6A4-95A45AF63CE4Q42111239-6019D05C-12D8-4F92-A2C9-41A18E452820Q42375699-21B7EDBB-645B-4473-BE92-07F57FC51E8C
P2860
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activities of daptomycin and v ...... imental model of endocarditis.
@en
Activities of daptomycin and v ...... imental model of endocarditis.
@nl
type
label
Activities of daptomycin and v ...... imental model of endocarditis.
@en
Activities of daptomycin and v ...... imental model of endocarditis.
@nl
prefLabel
Activities of daptomycin and v ...... imental model of endocarditis.
@en
Activities of daptomycin and v ...... imental model of endocarditis.
@nl
P2860
P921
P356
P1476
Activities of daptomycin and v ...... imental model of endocarditis.
@en
P2093
Kerry L LaPlante
Suzanne Woodmansee
P2860
P304
P356
10.1128/AAC.00134-09
P407
P577
2009-06-29T00:00:00Z